SEC Filings
venBio Fund Trades 253,826 ALX Oncology Shares For A Pre-Funded Warrant, Goodman Filing Shows
Corey Goodman's group still reports 9.99% of ALX Oncology after the exchange, and its amended filing states no new demands.
SEC Filings
Corey Goodman's group still reports 9.99% of ALX Oncology after the exchange, and its amended filing states no new demands.
SEC Filings
Fund 1's 13D amendment shows swap exposure of about 13.0% of Funko's shares, with no voting or disposition power attached.
SEC Filings
Dr. Gorjan Hrustanovic left the board and two committees effective October 14, the 13D amendment says, with no disagreement cited.
SEC Filings
Ares and its affiliated funds no longer own any Clear Channel Outdoor stock after the October 14 merger, a Friday filing says.
SEC Filings
The 8-K also shows an $89.7 million capped call and a new default of physical settlement for the 2030 and 2031 notes.
SEC Filings
J.P. Morgan is sole underwriter of the offering, which carried a combined public price of $40.00 and closed Friday, the 8-K says.
SEC Filings
The company's 8-K says the notice has no immediate effect on its listing, and a reverse split vote is set for October 23.
SEC Filings
An amended filing adds a $700,000 stock grant for Mike Hiller and a three-month advisory role for outgoing COO Steve Herron.
SEC Filings
The biotech set a $75.0 million gross offering price above Thursday's last reported sale of $1.91, with Morgan Stanley and BTIG leading.
SEC Filings
The $2.05 price sits about 7.3% above the October 15 close, and Alector says it will fund research, manufacturing and possible deals.
SEC Filings
The 8-K recasts segment data only; Eaton says it is not a restatement, and the company still plans to spin off Mobility.
SEC Filings
The company closed $730.0 million and €600.0 million note sales to retire 2027 debt and pushed its bank facilities to October 2031.